Problem
2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications
General information about the problem
The information on the stock of medications and medical devices handled at the central level is updated infrequently, inaccurately and incompletely (it is not clear which medications are available in hospitals and in what quantity). This sometimes makes it difficult for patients to receive free treatment, and for the state to effectively procure and distribute goods.
It should be emphasized that public procurement is carried out at the expense of the state budget according to the predetermined list of medications and medical devices. This is preceded by extensive work of groups of experts and specialists involved in the development of nomenclatures, terms of reference (“technical assignments”), etc. This process involves experts with relevant specialist knowledge – doctors and other healthcare professionals, as well as representatives of NGOs and patient organizations in whose activities private interests may prevail.
In addition, the relevant experts issue their recommendations and comments during the approval of procurement terms of reference (“technical assignments”), which should be taken into account by the State Enterprise Medical Procurement of Ukraine when formulating the final terms of reference, which, given the potential presence of private interest of the relevant experts, may negatively affect the objectivity of the approval of the relevant requirements.
As for decentralized (regional) procurement, there are different approaches of different customers to the procurement of the same type of medicinal products, which may lead to corruption risks both at the stage of tender documentation development and at the stages of bidding and contract execution.
Issues of interaction between pharmaceutical companies and healthcare professionals remain insufficiently regulated; proper regulation of these interactions would make it impossible to abuse the prescription of medicines to patients.
In addition to the procurement procedures themselves, an important aspect of preventing corruption risks in this field is the independence of the supervisory board of the state enterprise Medical Procurement of Ukraine. It should be emphasized that the state enterprise Medical Procurement of Ukraine falls under the criterion of critical enterprises, so the formation of a supervisory board is mandatory.
It should be emphasized that public procurement is carried out at the expense of the state budget according to the predetermined list of medications and medical devices. This is preceded by extensive work of groups of experts and specialists involved in the development of nomenclatures, terms of reference (“technical assignments”), etc. This process involves experts with relevant specialist knowledge – doctors and other healthcare professionals, as well as representatives of NGOs and patient organizations in whose activities private interests may prevail.
In addition, the relevant experts issue their recommendations and comments during the approval of procurement terms of reference (“technical assignments”), which should be taken into account by the State Enterprise Medical Procurement of Ukraine when formulating the final terms of reference, which, given the potential presence of private interest of the relevant experts, may negatively affect the objectivity of the approval of the relevant requirements.
As for decentralized (regional) procurement, there are different approaches of different customers to the procurement of the same type of medicinal products, which may lead to corruption risks both at the stage of tender documentation development and at the stages of bidding and contract execution.
Issues of interaction between pharmaceutical companies and healthcare professionals remain insufficiently regulated; proper regulation of these interactions would make it impossible to abuse the prescription of medicines to patients.
In addition to the procurement procedures themselves, an important aspect of preventing corruption risks in this field is the independence of the supervisory board of the state enterprise Medical Procurement of Ukraine. It should be emphasized that the state enterprise Medical Procurement of Ukraine falls under the criterion of critical enterprises, so the formation of a supervisory board is mandatory.
Expand...
Implementation of SACP measures within the limits of the problem
The total number of OSR –
7
All measures of the SACP
measures, the implementation of which as of
30.09.2024
is about to begin
to be completed
9
4
5
1
2
21
Implemented
Partially implemented
In progress
Not implemented
Not started
Measures implemented (fully and partially) - 13 (61.9%)
Deadlines for all measures
01.03.2023 -
31.12.2024
Implementation of SACP measures within the scope of the Problem by main main performers
Ministry of Health of Ukraine
19
Ministry of Economy of Ukraine
2
Achievement of ESR within the limits of the Problem
The total number of OSR – 7